|
|
|
l |
Home | l | UK Companies | l | Genomics Topics | l | Species with sequenced Genomes | l | Contact |
l |
Recent Publications by Featured Genomics Companies: | ![]() | ||
| AstraZeneca Pharmaceuticals | Imidazole piperazines: SAR and development of a potent class of cyclin-dependent kinase inhibitors with a novel binding mode.
A piperazine series of cyclin-dependent kinase (CDK) inhibitors have been... | Cancer and Infection Research Area, AstraZeneca Pharmaceuticals, Alderley | Bioorg Med Chem Lett. 2008 Aug 1;18(15):4442-6. Epub 2008 Jun 12. DOI Direct Link |
| AstraZeneca | An antibody panel for immunohistochemical analysis of the retina in Davidson's-fixed, paraffin-embedded eyes of rats.
Unlike most other tissues, the optimal fixative for preserving eye... | Department of Pathology, Safety Assessment, AstraZeneca, Alderley Park, | Exp Toxicol Pathol. 2008 Aug 19. DOI Direct Link |
| GlaxoSmithKline | Effect of Dutasteride on Intraprostatic Androgen Levels in Men With Benign Prostatic Hyperplasia or Prostate Cancer.
OBJECTIVES: Dutasteride exerts its beneficial effects on the prostate... | Urology Clinical Development and Medical Affairs, GlaxoSmithKline, | Urology. 2008 Aug 19. DOI Direct Link |
| GlaxoSmithKline | Epidemiology of opioid pharmacy claims in the United States.
OBJECTIVE: To describe opioid pharmacy claims patterns in the United... | Worldwide Epidemiology, GlaxoSmithKline, Research Triangle Park, North | J Opioid Manag. 2008 May-Jun;4(3):145-52. |
| GlaxoSmithKline Pharmaceuticals | The identification of potent, selective and CNS penetrant furan-based inhibitors of B-Raf kinase.
Modification of the potent imidazole-based B-Raf inhibitor SB-590885... | Department of Medicinal Chemistry, Neurology and GI Centre of Excellence | Bioorg Med Chem Lett. 2008 Aug 1;18(15):4373-6. Epub 2008 Jun 24. DOI Direct Link |
| GlaxoSmithKline | Effect of Dutasteride on Intraprostatic Androgen Levels in Men With Benign Prostatic Hyperplasia or Prostate Cancer.
OBJECTIVES: Dutasteride exerts its beneficial effects on the prostate... | Urology Clinical Development and Medical Affairs, GlaxoSmithKline, | Urology. 2008 Aug 19. DOI Direct Link |
| GlaxoSmithKline | Epidemiology of opioid pharmacy claims in the United States.
OBJECTIVE: To describe opioid pharmacy claims patterns in the United... | Worldwide Epidemiology, GlaxoSmithKline, Research Triangle Park, North | J Opioid Manag. 2008 May-Jun;4(3):145-52. |
Patents: | ![]() | |
| Company | US Patent No. | Title |
| Syngenta | 7414183 | Inbred corn line G07-NPAF5359 |
| Syngenta | 7414178 | Soybean cultivar S07-02KG294306 |
| Syngenta | 7414175 | Soybean cultivar S06-BA046119 |
| Syngenta | 7414064 | 4-(3,3-dihalo-allyloxy) phenoxy alkyl derivatives |
| Syngenta | 7411119 | Inbred corn line G07-NP2457 |
| Syngenta | 7411116 | Inbred corn line G5205 |
| AstraZeneca | 7411074 | Process and intermediates for the preparation of the thienopyrrole derivatives |
| AstraZeneca | 7411070 | Form of S-omeprazole |
| AstraZeneca | 7410972 | Compounds |
| Syngenta | 7410967 | Pyridodiazines as plant fungicides |
|